Gonadotropin-releasing hormone agonist or human chorionic gonadotropin for final oocyte maturation in an oocyte donor program
- 15 January 2010
- journal article
- Published by Elsevier in Fertility and Sterility
- Vol. 93 (2), 374-378
- https://doi.org/10.1016/j.fertnstert.2008.12.015
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Clinical factors affecting endometrial receptiveness in oocyte donation cyclesFertility and Sterility, 2008
- Triggering of final oocyte maturation with gonadotropin-releasing hormone agonist or human chorionic gonadotropin. Live birth after frozen-thawed embryo replacement cyclesFertility and Sterility, 2007
- Triggering ovulation with gonadotropin-releasing hormone agonists does not compromise embryo implantation ratesFertility and Sterility, 2006
- Comparison between a GnRH antagonist and a GnRH agonist flare-up protocol in oocyte donors: a randomized clinical trialHuman Reproduction, 2006
- GnRH agonist for triggering final oocyte maturation in the GnRH antagonist ovarian hyperstimulation protocol: a systematic review and meta-analysisHuman Reproduction Update, 2005
- GnRH agonist versus GnRH antagonist in oocyte donation cycles: a prospective randomized studyHuman Reproduction, 2005
- Use of GnRH antagonists in ovarian stimulation for assisted reproductive technologies compared to the long protocolArchiv für Gynäkologie, 2001
- The ovarian hyperstimulation syndromeFertility and Sterility, 2000
- Implantation rates after in vitro fertilization and transfer of a maximum of two embryos that have undergone three to five days of cultureFertility and Sterility, 2000
- Ovarian hyperstimulation syndrome in novel reproductive technologies: prevention and treatmentFertility and Sterility, 1992